DNMT3A mutation promotes leukemia development through NAM-NAD metabolic reprogrammingXuejiao Yang, Yueying Wang, Zhiyang Li et al.|Journal of Translational Medicine|2023Cited by 12
Cooperation of Dnmt3a R878H with Nras G12D promotes leukemogenesis in knock-in mice: a pilot studyXiaodong Shi, Yueying Wang, Ying Yang et al.|BMC Cancer|2019Cited by 8
NAM-NAD+-ADO metabolic reprogramming is a key factor for DNMT3A mutation to promote leukemia development through regulating cell cycle and immune microenvironmentYueying Wang, Siqi Shang, Yunshuo Chen et al.|Research Square|2022Cited by 0